Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy

Nephron

Volumn 87, Issue 3, 2001, Pages 231-239

  Abe, Katsushige ^a   Miyazaki, Masanobu ^a   Koji, Takehiko ^a   Furusu, Akira ^a   Shioshita, Kei ^a   Tsukasaki, Shoko ^a   Ozono, Yoshiyuki ^a   Harada, Takashi ^a   Sakai, Hideto ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Complement C3; IgA nephropathy; In situ hybridization; Membrane attack complex

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; MESSENGER RNA;

ARTICLE; BIOSYNTHESIS; BOWMAN MEMBRANE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CORRELATION FUNCTION; GLOMERULUS EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOGLOBULIN A NEPHROPATHY; IN SITU HYBRIDIZATION; MESANGIUM; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; BIOPSY; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C3D; COMPLEMENT MEMBRANE ATTACK COMPLEX; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; RNA, MESSENGER;

EID: 17744388763     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045920     Document Type: Article

References (51)

1. IgA nephropathy
2. Pathogenesis of IgA nephropathy
3. The commonest glomerulonephritis in the world: IgA nephropathy
4. Follow-up evaluation of the first patients with IgA nephrology described at Necker hospital
5. IgA nephropathy
6. Immunogloblin A nephropathy
7. Natural history of primary glomerulonephritis with mesangial deposits of IgA
8. Glomerular lesion in patients with asymptomatic persistent and orthostatic proteinuria discovered on routine medical examination
9. Complement system in IgA nephropathy
10. Immunohistochemical study of the C5b-9 complex of complement in human kidneys
11. Human C'3: Evidence for the liver as the primary site of synthesis
12. Mononuclear phagocytes have the potential to synthesize the complete functional complement system
13. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway of human peripheral blood monocytes
14. Biosynthesis of complement by human monocytes
15. Synovial fibroblast-like cells synthesize seven proteins of the complement system
16. The third component of complement is transcribed and secreted by cultured human endothelial cells
17. Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro
18. Biosynthesis of complement factor H by human umbilical vein endothelial cells: Regulation by T cell growth factor and IFN-γ
19. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways
20. Local extrahepatic expression of complement genes C3, factor B, C2 and C4 is increased in murine lupus nephritis
21. C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells
22. Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines
23. Complement C3 gene expression and regulation in human glomerular epithelial cells
24. Human glomerular epithelial cells synthesize and secrete the third component of complement
25. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells
26. Endogenous complement C3 synthesis in immune complex nephritis
27. Intraglomerular C3 synthesis in human kidney detected by in situ hybridization
28. Expression of DAF mRNA and C3 mRNA in human diseased kidney
29. In situ expression of cytokines in IgA nephritis
30. PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis
31. Different expression of complement C3 synthesis in immune complex nephritis
32. C3, C4 factor B and HLA-DR-alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy
33. Renal cortical complement C3 gene expression in IgA nephropathy
34. Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9
35. Immunologic studies in IgA nephropathy
36. Circulating immune complexes, the concentration of serum IgA and the distribution of HLA antigens in IgA nephropathy
37. Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy
38. Detection of IgA class circulating immune complexes bound to anti-C3d antibody in patients with IgA nephropathy
39. Evidence for a specific IgA receptor in rat and human mesangial cells
40. A specific Fcγ receptor on cultured rat mesangial cells
41. Antigen-antibody complexes enhance the production of complement component C3 by human mesangial cells
42. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induced production of TNF-α and IL-6 and proliferation
43. Activation of the alternative pathway of complement by human serum IgA
44. Activation of rat complement by soluble and insoluble rat IgA immune complexes
45. Lack of complement activation by human IgA immune complexes
46. Complement activation in IgA nephropathy
47. Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy
48. Activated complement C3: A potentially novel predictor of progressive IgA nephropathy
49. C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells
50. Role of complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis
51. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy